Navigation Links
Fiserv makes over $1 billion, but profits decline

Milwaukee, Wis. Fiserv, which provides software and services to the financial and health-benefits industries, said its first-quarter revenues in 2006 were up 13 percent to $1.1 billion.

Net income was $116 million, down slightly from the $140 million the company made in the first quarter of 2005 on $973 million in revenues.

Fiserve's activities in the first quarter includ......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 04/26/06


Page: 1

Related biology technology :

1. Fiserv reports $113.5 million in Q1 profit
2. Former Fiserv exec to enter Business Hall of Fame
3. Fiserv acquires crime management software firm
4. Fiserv posts 30 percent quarterly loss
5. Fiserv reports stronger earnings and revenues
6. Fiservs Banklink chosen by Union Bank of California
7. Fiserv to partner with PassMark Security
8. Fiserv crosses Fortune 500 threshold
9. Fiserv acquires insurance, training product lines
10. Fiserv unit adds healthcare payment processor
11. Fiserv Reports Strong Earnings for Third Quarter of 2005
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... , ... March 23, 2017 , ... ... material that exhibits both viscous and elastic characteristics when deformed, which is identical ... exhibits properties to gently absorb compressive forces and return to its natural state ...
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseqâ„¢ ... developed with input from industry experts to ...
(Date:3/23/2017)... , March 23, 2017 Kineta, ... development of novel therapies in immuno-oncology, today announced ... lead" small molecule compounds that activate interferon response ... pathways and demonstrate immune-mediated tumor regression in a ... the study who demonstrated complete tumor regression to ...
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
Breaking Biology Technology:
(Date:3/7/2017)... , March 7, 2017 Brandwatch , the ... by The Prince,s Trust to uncover insights to support ... The Trust. The UK,s leading youth charity will be ... campaign results and get a better understanding of the topics and ... ...
(Date:3/2/2017)... YORK , March 2, 2017 Summary ... better understand Perrigo and its partnering interests and activities since ... ... Partnering Deals and Alliance since 2010 report provides an in-depth ... leading life sciences companies. On demand company reports ...
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
Breaking Biology News(10 mins):